aescolab provides high-quality blood-biomarker analysis and indvidualized lifestyle recommendations supporting those that feel a lack of energy in their daily lives.

We want to help people take proactive action for their health and believe in a preventive approach to healthcare.

aescolab entered the German market in early 2024 to make high-quality blood analysis including individualized lifestyle recommendations available to more people suffering from fatigue symptoms such as exhaustion or lack of energy.

aescolab is supported by the leading Danish impact venture studio KRING.

aescolab

Org chart

Teams

Offices